JA
John Edward Adent (CEO) filed 1 Form 4 report in the past 24 months (1 purchase, 0 sales), most often in Neogen Corporation (NEOG). Across 1 priced purchase filing, the average 21-session return was -11.8% from execution and -11.8% from disclosure (delay-adjusted; derived). The largest single filing was $254K of NEOG (23,035 sh × $11.03, as filed), executed Jan 16 2025. Data as of Nov 8 2026.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
-11.8%
avg across 1 priced filings
Delay-adjustediThe same average, entered at disclosure dates
-11.8%
same 1 filings, from disclosure
Filings, ttm
1
1 buys · 0 sells
Median delay
0d
execution → disclosure
Volume, ttmiDollar value disclosed in the trailing twelve months
$254K
shares × price, as filed
Last traded
Jan 16 2025
Filed Jan 16 2025
Median ADV $40.8M across their filed names
Open performance→Volume by month
Buys $254K
Sells $0
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
1 filing
Sector per market data · by filing · past 24 months
Most traded names
NEOG
Neogen Corporation
NEOG · 1 buy · 0 sells
1 filing
Recent filings
NEOGPURCHASE
Neogen Corporation
View filing →
$254K23,035 sh × $11.03
Exec Jan 16 2025
Filed Jan 16 2025 · 5:30 PM ET